{"nct_id":"NCT02536300","title":"Dose Optimization Study of Idelalisib in Follicular Lymphoma","status":"TERMINATED","status_verified_date":"2023-08","start_date":"2016-01-14","start_date_type":"ACTUAL","primary_completion_date":"2022-09-27","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-27","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}